Partilhar
Informação da revista
Número
Vol. 41. Núm. 10.Páginas 813-898 (outubro 2022)
Original articles
Pirfenidone alleviates vascular intima injury caused by hyperhomocysteinemia
Junying Kong, Ying Deng
Rev Port Cardiol. 2022;41:813-9
Open access
Original Articles
Editorial comment
Homocysteinemia and vascular disease: Where we stand in 2022
R. Palma Reis
Rev Port Cardiol. 2022;41:821-2
Open access
Impact of the withdrawal of renin-angiotensin-aldosterone inhibitors on mortality in COVID-19 patients
Juan Caro-Codón, Juan R. Rey, Angel M. Iniesta, Sandra O. Rosillo, Sergio Castrejon-Castrejon, Laura Rodriguez-Sotelo, Jose M. Garcia-Veas, Irene Marco, ... on behalf of the CARD-COVID Investigators (Appendix)
Rev Port Cardiol. 2022;41:823-30
Open access
Original Articles
Editorial comment
Renin-angiotensin-aldosterone system inhibitors and the COVID-19 epidemic
José Silva-Cardoso, Emilia Moreira
Rev Port Cardiol. 2022;41:831-2
Open access
Alteration in serum oxidative stress balance in patients with different circulating high-density lipoprotein cholesterol levels
Mustafa Karabacak, Bayram Ali Uysal, Ahmet Kenan Turkdogan
Rev Port Cardiol. 2022;41:833-9
Open access
Original Articles
Editorial comment
Oxidative stress and high-density lipoprotein cholesterol: Cause or consequence?
Ana Cristina Gonçalves
Rev Port Cardiol. 2022;41:841-2
Open access
Coronary artery fistulas: A 12-year single-center experience
Sofia Torres, Mariana Vasconcelos, Marta Tavares Silva, Jorge Moreira, João Carlos Silva, Filipe Macedo
Rev Port Cardiol. 2022;41:843-50
Open access
Original Articles
Editorial comment
Coronary artery fistulas: A Portuguese single-center experience
Sérgio Madeira
Rev Port Cardiol. 2022;41:851-2
Open access
Beta-blocker use in patients with heart failure with preserved ejection fraction and sinus rhythm
Francesc Formiga, David Chivite, Julio Nuñez, Ma Carmen Moreno García, Luis Manzano, José Carlos Arévalo-Lorido, Jose Manuel Cerqueiro, Álvaro García Campos, ... on behalf of the RICA Investigators group
Rev Port Cardiol. 2022;41:853-61
Open access
Original Articles
Editorial comment
Medical therapy for heart failure with preserved ejection fraction: Still a minefield, but with new hope
Matteo Pagnesi, Antonio M. Sammartino, Marco Metra
Rev Port Cardiol. 2022;41:863-4
Open access
Systematic review
Candidate microRNAs as prognostic biomarkers in heart failure: A systematic review
Rita Figueiredo, Rui Adão, Adelino F. Leite-Moreira, Jennifer Mâncio, Carmen Brás-Silva
Rev Port Cardiol. 2022;41:865-85
Open access
Case report
Takotsubo syndrome in a breast-feeding young woman: Highlighting the protection of oestrogens?
Diogo Rodrigues Brás, Pedro Semedo, Bruno Cordeiro Piçarra, Pedro Dionísio, João Carvalho, Rui Azevedo Guerreiro, Kisa Congo, José Aguiar
Rev Port Cardiol. 2022;41:887.e1-887.e5
Open access
Case Report
Editorial comment
What is the role of estrogen in predisposition to Takotsubo syndrome throughout a woman's reproductive life?
Ana Rita Almeida
Rev Port Cardiol. 2022;41:889-90
Open access
Image in cardiology
Pneumopericardium and squamous cell lung carcinoma
Carla Marques Pires, Leonor Meira
Rev Port Cardiol. 2022;41:891-2
Open access
Letters to the editors
Takotsubo syndrome in the setting of COVID-19: Pathogenetic and diagnostic implications
Kenan Yalta, Gokay Taylan, Tulin Yalta, Ertan Yetkin
Rev Port Cardiol. 2022;41:893-4
Open access
Reply to the Letter to the Editor: Takotsubo syndrome in the setting of COVID-19: Pathogenetic and diagnostic implications
Kristian Rivera, Diego Fernández-Rodríguez, Marta Zielonka, Juan Casanova-Sandoval
Rev Port Cardiol. 2022;41:895
Open access
Light at the end of the tunnel of preserved heart failure, although important improvements are still necessary
Julio Núñez, Rafael de la Espriella, Francesc Formiga
Rev Port Cardiol. 2022;41:897-8
Open access
Publicar em
Revista Portuguesa de Cardiologia
A revista pertence ao Committee on Publication Ethics (COPE) www.publicationethics.org e adere aos seus princípios e procedimentos.